Waters Subsidiary Completes $3.5 Billion Senior Notes Offering to Refinance Acquisition Debt
WAT is trading near its 52-week low of $275.05 (9.7% above the low).
Summary
Waters Corporation's subsidiary completed a $3.5 billion senior notes offering to refinance debt related to its recent $16.8 billion acquisition.
Key Events · Financing and Capital Events · WAT
-
Completed $3.5 Billion Senior Notes Offering
Augusta SpinCo Corporation, a Waters subsidiary, completed a public offering of $3.5 billion in senior notes across five tranches with maturities ranging from 2027 to 2036 and interest rates from 4.321% to 5.245%.
-
Refinancing of Acquisition Debt
The net proceeds from the offering will be used to repay a $3.5 billion delayed draw term loan incurred in February 2026, which was part of the financing for the $16.8 billion acquisition of BD's Biosciences & Diagnostic Solutions business.
-
Parent Company Guarantee
The notes are fully and unconditionally guaranteed on a senior unsecured basis by Waters Corporation and certain of its subsidiaries.
-
Finalizes Prior Disclosure
This filing finalizes the terms and completion of the offering that was previously priced and disclosed on March 17, 2026.
Analysis · WAT · Industrial Applications And Services
Waters Corporation's subsidiary, Augusta SpinCo Corporation, has successfully completed a $3.5 billion public offering of senior notes. This offering finalizes the terms and pricing of the debt issuance that was initiated on March 17, 2026. The proceeds from this offering will be used to repay a $3.5 billion delayed draw term loan incurred in February 2026, which was a key financing component for the recently closed $16.8 billion acquisition of BD's Biosciences & Diagnostic Solutions business. The successful completion of this substantial refinancing provides financial certainty and strengthens the company's capital structure following the major acquisition.
At the time of this filing, WAT was trading at $301.81 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $29.6B. The 52-week trading range was $275.05 to $414.15. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.